Dr. Wendy Liu
Wendy joined Plaisance Capital in 2022 as a senior associate. Wendy brought to Plaisance many years of experience in business development and project management. She is familiar with the entire workflow of drug discovery from target validation to IND filing.
Prior to joining Plaisance, she served as the Director of Business Development at WuXi AppTec, and was taking care of biotech portfolio management for the Northeast region. Wendy has worked with 500+ biotechs and pharmaceutical companies, and was actively engaging 150+ companies on an annual basis. She has supported the growth of many companies from idea stage to clinical settings and beyond.
Wendy holds a Ph.D. from Georgia Institute of Technology, a M.S. from Washington University in St. Louis. Her research was focused on regenerative medicines in musculoskeletal system and nerve repair.